NCT04523831View on ClinicalTrials.gov

Clinical Trial of Ivermectin Plus Doxycycline for the Treatment of Confirmed Covid-19 Infection

PHASE3CompletedINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

June 1, 2020

Primary Completion Date

August 22, 2020

Study Completion Date

September 10, 2020

Conditions
Covid19
Interventions
DRUG

Ivermectin and Doxycycline

Ivermectin 6 mg, 2 tab stat and Doxycycline 100 mg twice daily for 5 days

DRUG

Standard of care

Paracetamol, Vitamin D, Oxygen if indicated, Low molecular weight heparin, dexamethasone if indicated

Trial Locations (1)

1000

Dhaka Medical College, Dhaka

Sponsors
All Listed Sponsors
lead

Dhaka Medical College

OTHER